Ceretas (ASX:CTS) — Material Events
ASX:CTS · 2 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Ceretas Limited Launches $8 Million IPO to Advance Alzheimer’s Ultrasound TherapyHigh
Ceretas Limited launches $8 million IPO to fund clinical trials and development of therapeutic ultrasound device for Alzheimer's treatment
21 July 2026
·Prospectus
·85
Ceretas Reports $1.63 Million Loss as $8 Million IPO Fuels Alzheimer’s Ultrasound Device ProgressMedium
Ceretas Limited reports FY26 loss of $1.63 million on $1.28 million revenue, completes $8 million IPO to fund Alzheimer's-focused ultrasound device development
31 Aug 2026
·Annual Report and Financial Statements
·80
No articles in this tier for the last 12 months.
Market Mentions
1
- appeared in market wrap coverage
These are market wrap articles where Ceretas (ASX:CTS) was mentioned. They reflect broader market coverage, not company-specific announcements.
Healthcare Wrap - Week 30 (20 July -> 24 July) 2026
25 July 2026